SynthesisEuropean journal of clinical pharmacology2014

Efficacy and safety of adalimumab for the Crohn's disease: a systematic review and meta-analysis of published randomized placebo-controlled trials.

Yun-Na Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.